Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 14
2004 11
2005 14
2006 16
2007 32
2008 21
2009 31
2010 38
2011 27
2012 29
2013 35
2014 22
2015 25
2016 18
2017 14
2018 10
2019 21
2020 19
2021 18
2022 16
2023 14
2024 11
2025 11
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alexander de la taille (2 results)?
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Perioperative Apalutamide in High-Risk Localized Prostate Cancer.
Taplin ME, Gleave M, Shore ND, Lopez-Gitlitz A, Kretschmer A, Efstathiou E, Nguyen PL, Damião R, Kamoto T, Ross A, Briganti A, Hadaschik BA, Heidenreich A, Juárez Soto Á, Ye H, Gotto G, Rooney B, Tian SK, Wetherhold L, Miladinovic B, McCarthy SA, Evans CP, Kibel AS; PROTEUS Investigators. Taplin ME, et al. N Engl J Med. 2026 Aug 6;395(6):546-560. doi: 10.1056/NEJMoa2603878. Epub 2026 May 31. N Engl J Med. 2026. PMID: 42223077 Clinical Trial.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; HERO Study Investigators. Shore ND, et al. N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469183 Clinical Trial.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. Beltran H, et al. Among authors: de la taille a. Cancer Discov. 2011 Nov;1(6):487-95. doi: 10.1158/2159-8290.CD-11-0130. Cancer Discov. 2011. PMID: 22389870 Free PMC article.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Stroma in normal and cancer wound healing.
Huet E, Jaroz C, Nguyen HQ, Belkacemi Y, de la Taille A, Stavrinides V, Whitaker H. Huet E, et al. Among authors: de la taille a. FEBS J. 2019 Aug;286(15):2909-2920. doi: 10.1111/febs.14842. Epub 2019 Apr 15. FEBS J. 2019. PMID: 30958920 Free article. Review.
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.
Rozet F, Ruffion A, Lemercier P, Soulié M, Robert G, Walz J, De La Taille A, Salomon L, Pfister C, Mathieu R, Vincendeau S, Descazaud A, Latorzeff I, Brureau L, Colombel M, Rouprêt M, Roca L, Pérez C, Marion S, Barret E, Cathelineau X, Fizazi K, Culine S; GETUG-20 Investigators. Rozet F, et al. Among authors: de la taille a. Eur Urol Oncol. 2026 Apr;9(2):369-377. doi: 10.1016/j.euo.2025.11.009. Epub 2026 Jan 3. Eur Urol Oncol. 2026. PMID: 41486043 Clinical Trial.
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
Scuderi S; Targeted Biopsies Prostate Cancer Collaborative Group; Tin AL, Marra G, Bianchi L, Kesch C, Soeterik TFW, Ploussard G, Zattoni F, Ettala O, Røder A, Poyet C, Müntener M, Umbehr M, Stroomberg HV, Cimmino U, Fiard G, Nordström T, Patel HD, Gupta GN, Yonover PM, Guillaume B, Gaffney C, Zhuang J, Wang Y, Sarkis J, Jabbour T, Diamand R, Windisch O, Olivier J, Abbadi A, Kim EH, Wang JC, Hu J, Zhu A, Stabile A, Eastham JA, Montorsi F, Briganti A, Gandaglia G; European Association of Urology (EAU) Young Academic Urologists YAU Prostate Cancer Working Party; Vickers AJ. Scuderi S, et al. J Natl Cancer Inst. 2026 Jan 1;118(1):76-84. doi: 10.1093/jnci/djaf275. J Natl Cancer Inst. 2026. PMID: 41002165
393 results